Arthropod-borne viruses (arboviruses) pose a considerable threat to human and animal health, yet effective control measures have proven difficult to implement, and novel means of controlling their replication in arthropod vectors, such as mosquitoes, are urgently required. One of the most exciting approaches to emerge from research on arthropods is the use of the endosymbiotic intracellular bacterium Wolbachia to control arbovirus transmission from mosquito to vertebrate. These a-proteobacteria propagate through insects, in part through modulation of host reproduction, thus ensuring spread through species and maintenance in nature. Since it was discovered that Wolbachia endosymbiosis inhibits insect virus replication in Drosophila species, these bacteria have also been shown to inhibit arbovirus replication and spread in mosquitoes. Importantly, it is not clear how these antiviral effects are mediated. This review will summarize recent work and discuss determinants of antiviral effectiveness that may differ between individual Wolbachia/vector/arbovirus interactions. We will also discuss the application of this approach to field settings and the associated risks.
Introduction
Arthropod-borne viruses (arboviruses) are transmitted in nature between susceptible vertebrate hosts and bloodfeeding arthropod vectors, such as mosquitoes, sandflies, midges and ticks. Upon infection with arboviruses, vertebrate hosts can develop a range of symptoms from mild to severe, including encephalitis and haemorrhagic fever. Arthropod vectors acquire a lifelong, generally asymptomatic infection through feeding on viraemic vertebrates. Following the initial replication in midgut or hindgut epithelial cells, virus is released into the haemocoel from where it disseminates to other tissues, most importantly the salivary glands and ducts. The transmission cycle is completed when arboviruses present in the arthropod's saliva are passed to a vertebrate host during a subsequent bloodmeal. Arbovirus distribution is dependent on the presence of vector species in a given area. Changes in climate and vector distribution, and an increase in urbanization, human travel and livestock movements, can all potentially impact on arbovirus transmission (Weaver & Reisen, 2010) . Most arboviruses are grouped into four RNA virus families, and include the positive strand Togaviridae and Flaviviridae, the negative strand segmented Bunyaviridae and the dsRNA segmented Reoviridae (Weaver & Reisen, 2010) .
Control of arboviral disease may be achieved by a number of measures, such as vaccination or the development of antiviral drugs; however, these are often not available and/or prove difficult to develop. For example, there is no effective vaccine for dengue virus (DENV; Flaviviridae), which impacts significantly on human health worldwide (Halstead, 2012) or emerging arboviruses, such as the alphavirus chikungunya (CHIKV; Togaviridae).
Indeed, preventing transmission from arthropod vector to vertebrate, and thus preventing infection altogether, may present a valuable alternative in combating arboviral disease. Vector eradication programmes form part of such strategies. In the past, sterile mosquitoes have been released, and more recently, genetic modification techniques have been used successfully to control mosquito populations (Alphey et al., 2013; Black et al., 2011; Lacroix et al., 2012; Wilke & Marrelli, 2012) . However, because one approach alone is unlikely to be sufficient and/or always applicable, novel strategies that work at the level of vector control are required.
In this context, current efforts to manipulate transmission of arboviruses by mosquitoes through the use of the bacterium Wolbachia merit greater attention. As RNA virus replication is inhibited by these endosymbionts in the model arthropod Drosophila melanogaster (Hedges et al., 2008; Teixeira et al., 2008) , Wolbachia has also been used to control arbovirus replication in mosquitoes and their transmission to vertebrates.
Wolbachia and reproductive phenotypes
Wolbachia is a genus of intracellular a-proteobacteria (family Rickettsiaceae), which is thought to infect 40-75 % of all arthropod species and several nematodes (Hilgenboecker et al., 2008; Zug & Hammerstein, 2012) . First discovered in the mosquito Culex pipiens (Hertig & Wolbach, 1924) , these bacteria have now been found in a number of vector mosquito species, although not the major arbovirus vector Aedes aegypti (Kittayapong et al., 2000; Sinkins, 2004) .
Wolbachia has been extensively studied because of its ability to significantly alter the biology of the host in the symbiotic relationship. These alterations are thought to dramatically increase the spread of the bacteria through insect populations and include male killing, parthenogenesis, feminization and cytoplasmic incompatibility (CI) . In mosquito populations, Wolbachia is spread and maintained through unidirectional and bidirectional CI (Kambhampati et al., 1993; Sinkins, 2004; Yen & Barr, 1973) , and our understanding of this process is vital to successful introduction of Wolbachia-infected mosquitoes into wild populations (as discussed in the final section of this review). The process of CI is explained below and summarized in Fig. 1 .
Alterations in spermatogenesis during male development result in the failure of Wolbachia-infected males to produce offspring when mating with either uninfected females (unidirectional CI) or females infected with a different strain of Wolbachia (bidirectional CI) (Fig. 1) . The altered sperm results in late entry of the male pronucleus into mitosis. Thus, the parental chromosomes fail to align properly and haploid embryos are produced. The presence of compatible Wolbachia in fertilized eggs, through vertical transmission, rescues CI (Landmann et al., 2009; Stouthamer et al., 1999; Tram et al., 2006; Tram & Sullivan, 2002) . Importantly, females infected with Wolbachia can mate successfully with uninfected males, giving them an evolutionary advantage over uninfected females, as they produce viable offspring with both infected and uninfected males (Turelli & Hoffmann, 1991 Yen & Barr, 1971) .
As early as the 1960s, mosquitoes that exhibited CI were considered a viable option for the control of disease vectors. One study reported the large scale release of Wolbachiainfected C. pipiens into wild populations in order to eliminate this population from a large urban area (Laven, 1967) . More recently, a virulent strain of Wolbachia found in laboratory strains of D. melanogaster, wMelPop, was cited as a possible mechanism for the control of mosquito populations and consequently the spread of arboviruses through transinfection (see below) (Brownstein et al., 2003; Yeap et al., 2011) . This particular strain of Wolbachia is known to infect Drosophila at a high density and reduce lifespan. It has since been shown that it is possible to transinfect Aedes albopictus and Ae. aegypti populations with wMelPop and other Wolbachia strains, and for them to be stably maintained in populations (Blagrove et al., 2013; McMeniman et al., 2009; Xi et al., 2005 Teixeira et al., 2008) . The remainder of this review will discuss this in more detail.
Wolbachia and antiviral activity in insects

Studies in the model Drosophila
Initial studies carried out in D. melanogaster concluded that the Wolbachia strains wMelCS and wMelPop increased fly longevity upon infection with the RNA viruses Drosophila C virus (DCV; Dicistroviridae), Flock House virus (FHV; Nodaviridae) and cricket paralysis virus (CrPV; Dicistroviridae), but not the DNA virus insect iridescent virus 6 (IIV-6; Iridoviridae) (Hedges et al., 2008; Teixeira et al., 2008) . Moreover, viral titres were significantly reduced in the presence of Wolbachia in the case of DCV and nora virus (NoraV; a potentially novel family within the Picornavirales).
Further studies in Drosophila simulans, which are naturally infected with multiple Wolbachia strains, showed that only those Wolbachia strains that are present in high densities (wMel, wRi and wAu), conferred antiviral resistance to DCV and FHV. In DCV-infected D. simulans, Wolbachiamediated protection did not directly correlate with reduced viral copy numbers (Osborne et al., 2009) . For example, wRi significantly increased lifespan upon infection with DCV compared to controls; however, there was no significant decrease in virus accumulation. Conversely, Teixeira et al. (2008) and Hedges et al. (2008) showed that DCV titres in D. melanogaster were strongly reduced by Wolbachia infection (Hedges et al., 2008; Teixeira et al., 2008) . During FHV infection, virus titre was unaffected but virusinduced pathology was decreased, resulting in increased life spans of infected flies (Teixeira et al., 2008) . A recent study also demonstrated that replication of the dsRNA virus bluetongue virus (BTV; Reoviridae) in D. melanogaster is inhibited in the presence of Wolbachia (Shaw et al., 2012) . Taken together these data suggest that reduction of viral titres is not the only mechanism responsible for Wolbachiamediated protection. These findings in the model organism Drosophila have led to considerable interest in the field of human-pathogenic mosquito-borne viruses. The key findings are summarized in Table 1 .
Mosquitoes and Wolbachia-mediated antiviral activity
Aedes and Culex species are the major arthropod vectors for DENV, West Nile virus (WNV) and yellow fever virus (YFV) (all Flaviviridae), as well as CHIKV (Togaviridae) (Weaver & Reisen, 2010) . Among the major arbovirus vectors, Ae. albopictus, Aedes bromeliae and members of the C. pipiens complex are naturally infected with Wolbachia endosymbionts (Ae. albopictus harbours wAlbA and wAlbB, and C. pipiens wPip) (Armbruster et al., 2003; Hertig & Wolbach, 1924; Kittayapong et al., 2000; Osei-Poku et al., 2012; Sinkins et al., 1995) , whereas Ae. aegypti mosquitoes lack this association (Table 2 ).
Unlike the above-mentioned native Drosophila/Wolbachia interactions, the ability of homologous Wolbachia strains to confer resistance in mosquitoes is limited by tissue density and distribution. For example, wAlbA and wAlbB did not inhibit DENV replication to significant levels in Ae. albopictus mosquitoes (Bian et al., 2010) , but reduced viral infection of the salivary glands and thus may limit transmission (Mousson et al., 2012) . Furthermore, the wAlbA and wAlbB infected Ae. albopictus cell line Aa23 showed decreased DENV titres compared to Wolbachiacured controls. Notably this cell line has a significantly higher Wolbachia density than somatic tissues of Ae. albopictus, which may explain its restrictive phenotype . A study of the interaction between CHIKV and wAlbA and wAlbB in Ae. albopictus mosquitoes showed no decrease in viral titres in the presence of Wolbachia compared to controls. Viral titres in Wolbachia-free mosquitoes were extremely variable compared to those harbouring Wolbachia, suggesting some level of interaction (Mousson et al., 2010) . Lastly, homologous wPip infections in Culex quinquefasciatus resulted in reduced WNV titres and transmission rates (Glaser & Meola, 2010) . Given that Wolbachia confers resistance to RNA viruses in Drosophila (Hedges et al., 2008; Teixeira et al., 2008) , and that Wolbachia strains can be stably introduced and maintained in heterologous host mosquitoes (Blagrove et al., 2013; McMeniman et al., 2009; Xi et al., 2005) , multiple studies have investigated whether Wolbachia transinfection into different mosquito species would result in vectors refractory to infection with important viral pathogens.
Transinfection and resulting phenotypes
Transinfection of mosquitoes with heterologous Wolbachia strains is by no means trivial, as not all hosts are equally permissive and Wolbachia strains differ in their ability to stably transfect certain new host species . Most likely as a consequence of evolutionary adaptation to their hosts, naturally occurring Wolbachia strains differ in their genome organization and in the reproductive phenotypes they cause (reviewed by Serbus et al., 2008; Werren et al., 2008) . In nature, Wolbachia cross-species transmission events occur frequently (Haine et al., 2005; Heath et al., 1999; Huigens et al., 2000 Huigens et al., , 2004 Kraaijeveld et al., 2011; Vavre et al., 1999; Werren et al., 1995) and are thought to result in a loss of infection or, if infection is established, in a temporary increase in virulence, caused either by competition for resources or by disproportional host immune activation (Le Clec'h et al., 2012; Lipsitch Table 2 ). For example, in wMel-transinfected Ae. aegypti, WNV was not inhibited, whereas the presence of the wMelPop strain of Wolbachia significantly reduced WNV replication . Similarly, wMelPop-CLA, and to a lesser extent wMel, was able to diminish YFV replication and dissemination in transinfected Ae. aegypti (van den Hurk et al., 2012) . In the same study it has been shown that wMel can only inhibit infection and dissemination of CHIKV in transinfected Ae. aegypti upon viraemic bloodmeal, but not upon intrathoracic inoculation (van den Hurk et al., 2012). More recently, wMel transinfection in Ae. albopictus was found to prevent CHIKV dissemination to the salivary glands and thus possibly viral transmission (Blagrove et al., 2013) .
Further studies have shown that transinfection of Ae. aegypti with the D. melanogaster wMelPop-CLA strain of Wolbachia negatively affects mosquito survival and strongly inhibits the replication of DENV when compared to tetracycline-treated (cured of Wolbachia infection) control or wild-type mosquitoes, irrespective of whether mosquitoes were blood fed or whether virus was injected intrathoracically (Moreira et al., 2009) . Wolbachia also reduced DENV dissemination to the thorax and head of mosquitoes, and hence possibly transmission (Bian et al., 2010; Moreira et al., 2009) . Ae. aegypti transinfected with the Ae. albopictus Wolbachia strain wAlbB also showed increased mosquito longevity upon infection with DENV and suppressed viral replication (Bian et al., 2010) .
It would appear that the Wolbachia-induced virus refractory phenotype is dependent on the combination of Wolbachia strain, virus and host (genetic or other) factors. Understanding these differences is key to a successful vector control protocol. Several mechanisms have been proposed to explain why Wolbachia inhibits arbovirus transmission effectively in some scenarios but not in others. These will be discussed below.
Determinants of Wolbachia viral interference in arthropod hosts
It is not known how Wolbachia endosymbionts confer antiviral resistance to their hosts, and in order to develop intervention strategies based on Wolbachia-mediated viral interference it is crucial to elucidate the underlying mechanisms. An important question to address is whether Wolbachia interferes with viral replication directly or whether it increases vector resistance to viral infection by other mechanisms. Furthermore, it is important to elucidate whether the Wolbachia-mediated effect is cell autonomous or systemic.
Wolbachia density and competition for host cell resources
Density. Early studies found a positive correlation between intracellular endosymbiont density and antiviral effect conferred Osborne et al., 2009 Osborne et al., , 2012 . Different Wolbachia strains are known to infect vector species at variable densities and to display different tissue distributions (Dobson et al., 1999; Dutton & Sinkins, 2004; Miller & Riegler, 2006) . In its native host Ae. albopictus, wAlbB is found both in reproductive tissues (ovaries, testes) and somatic tissues (haemolymph, midgut, muscle, head) (Dobson et al., 1999) . In somatic tissues, wAlbB levels can vary significantly between Ae. albopictus strains (Dobson et al., 1999) . In C. pipiens, Wolbachia densities can vary up to 100-fold between individual mosquitoes and also between populations, which could lead to differences in vector competence (Berticat et al., 2002; Echaubard et al., 2010; Glaser & Meola, 2010) . In heterologous hosts, however, Wolbachia usually grows to higher densities than in native hosts, which may explain why antiviral effects are more often observed in heterologous hosts compared to native host species (Glaser & Meola, 2010) . Examples of Wolbachia transinfections that resulted in increased bacterial densities and antiviral resistance compared to original vector species include infection of Ae. aegypti (Bian et al., 2010) or Aedes polynesiensis (Bian et al., 2013b) with wAlbB. An exception is wMelPop, which grows to high titres in D. melanogaster and leads to a reduced life span of the host and a reduction in viral replication (Hedges et al., 2008; Min & Benzer, 1997) .
It has been hypothesized that protection is dependent on whether Wolbachia-harbouring tissues and viral target cells or tissues co-localize (Bian et al., 2010; Moreira et al., 2009) . Interestingly, in C. pipiens Wolbachia is less abundant in the midgut than in other somatic tissues (Dobson et al., 1999) and may not be present to limit DENV replication in midgut epithelial cells (Glaser & Meola, 2010) . Density may also be important if it is simply a case of competition for space and/or cellular resources. Indeed there is little evidence of Wolbachia and virus being present together in the same cell/tissue when either is at a high density (Frentiu et al., 2010; Moreira et al., 2009) .
Autophagy. One mechanism that is thought to control the density of Wolbachia is autophagy. Infection of C6/36 cells (an Ae. albopictus-derived cell line) with wAlbB showed that Wolbachia not only induced the autophagy pathway but also manipulated it in order to ensure survival (Voronin et al., 2012) . This was also true for a naturally infected D. melanogaster line (wMelPop) (Voronin et al., 2012 In addition to iron homeostasis, the cholesterol metabolism needs to be tightly regulated to enable viral replication and bacterial growth. Insect cells are cholesterol auxotrophs (Clayton, 1964) , and can be depleted of cholesterol and other lipids by growth in delipidated serum (Hafer et al., 2009; Silberkang et al., 1983) ; however, they will incorporate low levels of cholesterol from serum (Mitsuhashi et al., 1983) . Wolbachia is unable to synthesize cholesterol de novo and thus its replication is cholesteroldependent (Lin & Rikihisa, 2003) . Further, inside host cells individual bacteria are contained within cholesterol-containing Golgi-related vesicles (see also Fig. 2 ) (Cho et al., 2011) . Cholesterol depletion of host cells by Wolbachia could also interfere with virus replication. A recent study has examined the involvement of cholesterol in Wolbachia-mediated DCV interference in D. melanogaster . It was shown that cholesterol enrichment of fly diets reversed the Wolbachia-mediated DCV interference effect and the increase in D. melanogaster life span in a dose-dependent manner. Importantly, dietary cholesterol levels did not affect Wolbachia densities in wMelCS-infected flies and did not affect DCV infection levels in Wolbachia-free flies . For wMelPop-infected flies there was a significant effect of diet on Wolbachia density; however, this did not affect pathogen blocking .
Both mosquito-borne alphaviruses and flaviviruses have been shown to rely on host cell lipids for their uptake, replication, virion assembly and infectivity. Sindbis virus (SINV; Togaviridae) and Semliki Forest virus (SFV; Togaviridae) are endocytically taken up into host cells, followed by cholesterol and sphingolipid-dependent fusion of the viral and host membranes at low pH (Kielian, 1995; Lu et al., 1999; Smit et al., 1999) . Their replication takes place in replication complexes on intracellular endosomederived membranes. In insect cells, virion assembly takes place in cytoplasmic vesicles that fuse with the plasma membrane in a cholesterol-dependent manner to release virus into the medium (Brown & Condreay, 1986 ). Therefore, the lipid content of viral particles resembles that of the producer cells (Hafer et al., 2009) . Several studies have shown that alphaviruses can grow to high titres in insect cells although their lipid content is generally low (Hafer et al., 2009; Mitsuhashi et al., 1983; Tsetsarkin et al., 2011) . Cholesterol depletion of C6/36 cells blocked SFV endosome membrane fusion, replication and exit (Chatterjee et al., 2000; Marquardt et al., 1993; Phalen & Kielian, 1991) . A significant reduction in the production of infectious SINV and SFV particles upon delipidation of C6/36 cells has been reported (Hafer et al., 2009; Lu et al., 1999; Marquardt et al., 1993; Phalen & Kielian, 1991) . It can be assumed that the lower infectivity of these particles was caused by an altered lipid composition, which resulted in a loss of stability and structural fragility of the produced virions. Interestingly, in addition to cholesterol other lipids seem to be essential for virion infectivity (Hafer et al., 2009 ).
Similar to alphaviruses, flavivirus replication relies on a tight regulation of host cell cholesterol biosynthesis (Carro & Damonte, 2013; Rothwell et al., 2009) . Although DENV was found to be insensitive to plasma membrane cholesterol depletion in C6/36 cells (Acosta et al., 2008; Mosso et al., 2008; Umashankar et al., 2008) , extraction of cholesterol from viral envelopes reduced DENV infectivity for C6/36 cells (Acosta et al., 2009 ). The differential dependence on host cell membrane cholesterol content seen between members of the families Togaviridae and Flaviviridae may be explained by the fact that the former viruses bud through the host cell plasma membrane so that the lipid composition of their envelopes resembles that of the cell membrane (Hafer et al., 2009; Sousa et al., 2011) . In contrast, the origin of the flavivirus envelope is the endoplasmic reticulum (Welsch et al., 2009 ), which contains only a small proportion of the total cell cholesterol (Lange et al., 1999) . Given the crucial role for cholesterol and other lipids in viral life cycles, it is not surprising that another flavivirus, WNV, has been shown to modulate host cell cholesterol levels by upregulating cholesterol biosynthesis and redistributing it to sites of virus replication (Mackenzie et al., 2007) . These cellular modifications are necessary for WNV replication to take place. In summary, these early experiments relating to Wolbachia, cholesterol and antiviral activity are intriguing and warrant further investigation as it is clear that cholesterol is important both for virus replication and Wolbachia growth.
Immune signalling in arthropod/Wolbachia interactions
As Wolbachia is now known to confer resistance to a broad range of RNA viruses, it could be assumed that the mechanism(s) behind antiviral activity would also be broad ranging. Innate immunity consists of a set of anti-microbial mechanisms largely conserved between insect species and is the first line of defence against invading microbes, including viruses (Bartholomay et al., 2010; Christophides et al., 2002; Lemaitre & Hoffmann, 2007; Waterhouse et al., 2007) . It is therefore plausible to suggest that Wolbachia may control viral infection by pre-activating the immune system, also known as immune priming. Much of our understanding of innate immunity in mosquitoes is influenced by key findings made in Drosophila studies (Fragkoudis et al., 2009; Lemaitre & Hoffmann, 2007; Merkling & van Rij, 2013; Wong et al., 2011) .
Toll, Imd and JAK-STAT
Among a number of mechanisms that limit bacterial infections, three major signalling pathways -Toll, Imd and JAK-STAT -control innate immunity. The Toll pathway is initiated upon infection with fungi or Gram-positive bacteria, leading to transcriptional upregulation of a specific subset of antimicrobial peptides (AMPs) and several other immune genes (Lemaitre & Hoffmann, 2007) . The Toll pathway has also been implicated in antiviral immunity. For example, the pathway is activated by the presence of the dsRNA virus Drosophila X virus (DXV; Birnaviridae) in Drosophila (Zambon et al., 2005) , and has been implicated in the control of DENV and WNV in mosquito studies (Smartt et al., 2009; Xi et al., 2008) . Stimulation with Gramnegative bacteria activates the Imd pathway, and induces immune genes and Imd-specific AMPs (Lemaitre & Hoffmann, 2007) . Several mutants in the Drosophila Imd pathway also exhibit higher CrPV titres compared to wildtype flies (Costa et al., 2009) . Studies in An. gambiae suggest the differential expression of Imd pathway genes in response to o'nyong'nyong virus (ONNV; Togaviridae); however, it would only appear to have a minor role in that particular host-virus interaction (Waldock et al., 2012) . A third pathway known to be involved in both bacterial and viral infection is the JAK-STAT pathway. DCV, for example, activates the JAK-STAT pathway in Drosophila resulting in the upregulation of genes such as vir1 (Dostert et al., 2005) . Studies in Ae. aegypti have demonstrated that DENV infection is controlled by JAK-STAT signalling (SouzaNeto et al., 2009; Xi et al., 2008) . Indeed, knockdown of key components of the JAK-STAT pathway resulted in significantly higher DENV viral titres. In the case of alphaviruses, a number of studies in Drosophila and mosquito cells suggest that the combination of Imd and/or JAK-STAT signalling, but not the Toll pathway, has antiviral activities (Avadhanula et al., 2009; Fragkoudis et al., 2008; Huang et al., 2013) . Importantly, this shows that at least when it comes to antiviral immune signalling, differences between virus families, but also within virus families and vectors (SINV/SFV versus ONNV), exist.
Early studies in Ae. aegypti mosquitoes transinfected with several different strains of Wolbachia indicated that immune priming may be involved in antiviral activity. For example, the transinfection of wMelPop-CLA into Ae. aegypti resulted in the upregulation of immune genes, including several involved in the Toll and Imd pathways (Kambris et al., 2010; Rancès et al., 2012) . Further transcriptional analysis of transinfected Ae. aegypti (wAlbB) showed significant upregulation of several Toll-dependent genes, in particular the AMP-encoding gene defensin (Bian et al., 2010) . These studies are, however, hampered by the initial transinfection of heterologous Wolbachia strains. Naturally infected D. melanogaster, D. simulans, and indeed, Ae. albopictus do not show this immune priming phenotype, and in the case of D. simulans and D. melanogaster (and to some extent Ae. albopictus) Wolbachia still confers resistance to several RNA viruses Osborne et al., 2009; Rancès et al., 2012; Teixeira et al., 2008) . Significantly, DENV infection is limited in both D. melanogaster and Ae. aegypti, which are infected with the strain wMel, to similar degrees (Rancès et al., 2012). Therefore, it is unlikely that the immune priming seen in Ae. aegypti is key to Wolbachiamediated protection, as there is no such priming in D. melanogaster. It has been shown that there was neither an induction nor suppression of AMPs in either D. simulans or Ae. albopictus naturally infected with different Wolbachia strains (see Tables 1 and 2 , respectively) and these insects are furthermore able to mount a normal response to bacterial infection (Bourtzis et al., 2000) . Immune priming of the Imd or Toll pathways would also suggest that Wolbachia had the ability to protect against further bacterial infection; however, again this is not the case (Rottschaefer & Lazzaro, 2012) . A more recent study has utilized the availability of Drosophila strains that are deficient in key components of the Imd and Toll pathway to conclude that neither a functional Toll nor an Imd pathway is required for the ability of Wolbachia to protect against DENV (Rancès et al., 2013).
The Toll pathway has also been shown to be induced by the production of reactive oxygen species (ROS) in Ae. aegypti mosquitoes transinfected with the heterologous Wolbachia strain wAlbB . The activation of the pathway in these mosquitoes leads to the production of the AMPs cecropin and defensin. Targeted reduction of these two AMPs resulted in an increase of DENV viral titres in these mosquitoes, leading to speculation that production of ROS and subsequent Toll activation may lead to Wolbachia-mediated antiviral activity. However, the corresponding experiment was not carried out in Wolbachiafree lines; therefore, the extent by which this activation leads to antiviral activity cannot be fully assessed . The broad activity of Wolbachia-mediated protection would argue against immune priming as the main mediator of antiviral activity, given the different susceptibilities between viruses to Toll, Imd and JAK-STAT pathways.
A recent study identified the phenoloxidase (PO) cascade as an important mosquito innate immune response to SFV (Rodriguez-Andres et al., 2012). Interestingly, Wolbachia has been shown to increase melanization through the PO cascade in both homologous and heterologous Wolbachia/ host settings (Thomas et al., 2011) . It is likely that the PO cascade acts to protect against other viruses, and therefore the interaction with Wolbachia is intriguing and would merit further investigation.
Taken together, the studies described above suggest that immune priming is not central to the protection that Wolbachia confers. However, as transinfection of Wolbachia strains to heterologous hosts often leads to some level of immune priming, the additive effect of this cannot be ignored. It may be that the amount of antiviral protection present in released mosquitoes is vital to the sustainability of vector/arbovirus control. Studies suggest that as there is little or no immune priming present in homologous Wolbachia/ host settings, over time co-evolution would lead to a reduction in the immune response. Therefore, it is crucial to understand to what extent immune priming plays a role in antiviral activity in transinfected hosts.
Small RNA pathways in arthropod/Wolbachia interactions
Further to the immune signalling pathways discussed above, mosquitoes respond to viral infection through the sequence-specific small RNA breakdown pathways, RNA interference (RNAi). RNAi is considered to be the most important antiviral response in insects and is key to the control of arboviruses in mosquitoes (Blair, 2011) . The exact mechanisms behind antiviral RNAi are beyond the reach of this review (see Donald et al., 2012 for a recent review). Nevertheless, as a mechanism that is known to successfully control a wide variety of arboviruses, it is important to ascertain if the RNAi response is involved in mediating the antiviral activity of Wolbachia. Several lines of evidence, however, suggest that it is not essential. Firstly, the Ae. albopictus cell line C6/36 does not contain a functional Dicer 2 protein, a key protein in the main antiviral RNAi response (Brackney et al., 2010; Scott et al., 2010) .
Transinfection of these cells with wMel still results in the inhibition of DENV, suggesting that a functioning exogenous RNAi response is not necessary for inhibition to occur (Frentiu et al., 2010) . Additionally, Drosophila mutants defective for several key components of the antiviral RNAi pathway infected with Wolbachia still show resistance to WNV, DCV and FHV when compared to control flies (Glaser & Meola, 2010; Hedges et al., 2012) . Taken together these results indicate that the main antiviral RNAi pathway is not essential for Wolbachia-mediated viral protection.
In addition to the RNAi pathway, the microRNA (miRNA) pathway has been implicated in the pathogen-blocking effect of Wolbachia (Hussain et al., 2011; Osei-Amo et al., 2012; Zhang et al., 2013) . miRNAs are nonprotein-coding small RNAs that are involved in the regulation of cellular development, differentiation, apoptosis and immunity (Asgari, 2013; Donald et al., 2012) . Recently, the expression of miRNAs in Ae. aegypti mosquitoes transinfected with wMelPop-CLA was studied (Hussain et al., 2011) . The presence of Wolbachia has been shown to alter the expression of several insect miRNAs. The induction of one miRNA, aae-miR-2940, by Wolbachia is of particular interest to this review. aae-miR-2940 has been shown to downregulate the expression of the metalloprotease m41 ftsh (Hussain et al., 2011) . Inhibition of this miRNA or silencing of the metalloprotease gene in mosquitoes reduced Wolbachia density (Hussain et al., 2011) . Importantly, upregulation of aae-miR-2940 by Wolbachia has been found to inhibit DENV replication. This effect on DENV is mediated by the downregulation of the Ae. aegypti DNA (cytosine-5) methyltransferase gene AaDnmt2, a second target of aae-miR-2940 (Zhang et al., 2013) . DNA cytosine methylation is essential for host defence, genome stability, gene regulation, organ differentiation and ageing. Reversely, overexpression of AaDnmt2 leads to a decrease in Wolbachia density, but an increase in DENV replication. In DENV-infected, Wolbachia-free mosquitoes, expression of AaDnmt2 is upregulated. In Wolbachia-free Ae. aegypti, aae-miR-2940 is, although at low levels, expressed so that AaDnmt2 levels are negligible (Zhang et al., 2013) . These findings point towards an important role of aae-miR-2940 in the maintenance of Wolbachia infection in Ae. aegypti as well as the resistance to DENV in Wolbachia-transinfected mosquitoes. Reduction in AaDnmt2 expression in Wolbachia-infected cells could lead to hypomethylation of the mosquito genome and thereby regulate expression of methylation-sensitive host genes (Zhang et al., 2013) . In fact, a recent study has confirmed this idea (Ye et al., 2013) .
In particular, expression of Ae. aegypti genes, with membrane functions, appear to be differentially regulated upon Wolbachia infection (Cho et al., 2011; Ye et al., 2013) .
In summary, the studies discussed above suggest that the RNAi pathway is not essential for Wolbachia-mediated antiviral activity, but that the miRNA pathway could affect viral replication either directly, through up or downregulation of genes involved in viral replication or antiviral activity, or indirectly, by altering the density of Wolbachia.
Applications, risks and future directions
Based on its pathogen-blocking effect Wolbachia introduction into wild mosquito populations has been suggested as a potential control measure for arboviruses. Previous introductions of genetically modified (GM) mosquitoes into wild populations have been met with public concern. However, Wolbachia is a naturally occurring symbiont of mosquitoes, and therefore infected vectors are not considered to be GM. Recent studies have also demonstrated that there is no antibody production against Wolbachia in human volunteers bitten by Wolbachia-infected mosquitoes, nor is there a transfer to the environment (be it mosquito predators, or soil, leaves, etc.) (Popovici et al., 2010) , suggesting that Wolbachia is a safe alternative to GM mosquitoes. Nevertheless, public engagement and detailed regulations, such as those set out by Hoffmann et al. (2011) , are key to public and scientific acceptance of such release experiments.
Release of Wolbachia-infected mosquitoes into wild mosquito populations, with the aim of fixation of the infection frequency (i.e. stable introduction of Wolbachia in previously non-infected vector populations), requires extensive knowledge of local and regional mosquito population densities and dispersion dynamics (Engelstädter & Telschow, 2009; Schofield, 2002) . Further parameters to consider include the strength of the Wolbachia-induced CI effect, maternal inheritance rates and fitness costs or advantages (for example refractoriness to viral infection) to the vector inferred by Wolbachia infection (Vavre & Charlat, 2012 ). Mathematical modelling approaches are then employed to calculate the minimum number of Wolbachia-infected mosquitoes to be released (Hancock & Godfray, 2012; Hoffmann et al., 2011; Hughes & Britton, 2013; Turelli, 2010; Walker et al., 2011) .
A key question is how sustainable a Wolbachia-mediated approach would be. In order to answer this question, we firstly need to distinguish between two mechanisms by which stable introduction of Wolbachia into wild populations can limit vector competence for pathogen transmission: (i) Wolbachia-mediated life-shortening of mosquitoes, which would interfere with viral transmission, and (ii) Wolbachia-induced vector refractoriness to infection, which would limit viral replication and transmission (Vavre & Charlat, 2012) . Modelling of the epidemiology of Wolbachia in host populations has suggested that vector/ Wolbachia associations would be more sustainable in the field using the former approach as host resistance to the bacterium is less likely to occur (Read et al., 2009; Schraiber et al., 2012) . However, it has been shown that mosquitoes carrying life-shortening Wolbachia strains, such as wMelPop, have to be released in very high numbers compared to mosquito populations present at the release site, and that they cannot invade regional mosquito populations (Hughes & Britton, 2013; McMeniman et al., 2009; Walker et al., 2011) . In contrast to the reduction of viral transmission due to Wolbachia-induced life-shortening, vector refractoriness is expected to diminish over time as a function of vector/Wolbachia co-adaptation (Vavre & Charlat, 2012) .
As discussed previously, the density of Wolbachia in transinfected mosquitoes, and indeed in homologous mosquito/Wolbachia combinations, is crucial to the Wolbachiamediated antiviral activity Osborne et al., 2009 Osborne et al., , 2012 . Therefore, any decrease in Wolbachia density due to mosquito/Wolbachia co-adaptation may lead to a significant decrease in antiviral activity. However, it is clear from studies in D. melanogaster that long-term vector/ Wolbachia/virus associations can lead to continued protection against viruses. For example, invasion of D. melanogaster by wMel occurred during the last 80 years (Riegler et al., 2005) , yet wMel still confers protection against DCV (Teixeira et al., 2008) . This is encouraging and further studies in this model system could be extremely beneficial to the field.
If, at some point, reintroductions of Wolbachia-infected mosquitoes are required, then understanding the mechanism of CI becomes important. CI will confer an evolutionary advantage to released mosquitoes over the wild population, which aids the spread and maintenance of Wolbachia within the wild population. It will, however, also limit the spread of newly introduced Wolbachia strains into the same population, as CI will prevent successful mating of the incoming mosquitoes with individuals of the original population (see Fig. 1 ).
Further to CI, the introduction of novel mosquito/ Wolbachia combinations is hindered by the aforementioned technical difficulties of transinfections. As Wolbachia transinfection between closely related species is more successful (Bian et al., 2010; Russell et al., 2009) , newly discovered Wolbachia strains of Ae. bromeliae (a YFV vector) and Aedes metallicus may be suitable candidates for introduction into aedine vectors (Osei-Poku et al., 2012) . Transinfection can also result in an evolutionary disadvantage within the mosquito, for example reduced fecundity or viability. This in turn could affect the spread within a population. Coupling Wolbachia introduction to insecticide resistance has been suggested in order to counteract these effects (Hoffmann & Turelli, 2013) . Spread of such resistance genes into wild populations requires careful evaluation and is dependent on local mosquito populations and control strategies.
The impact of introduced Wolbachia on the target virus may be complex. Modelling indicates that different Wolbachia strains have varying abilities to reduce transmission frequencies (R 0 ) (Bian et al., 2010; Hoffmann et al., 2011; McMeniman et al., 2009) , and if transmission is only partially blocked Wolbachia will place the target virus in a bottleneck, perhaps leading to the evolution of a virus resistant to Wolbachia-mediated protection. Furthermore, modelling of the co-evolution of parasites and protecting symbionts suggests increases in parasite virulence (Jones et al., 2011) . The implication -that exposure to Wolbachia might result in increased virulence of DENV or CHIKV -is of obvious concern. There is clearly a need for longterm studies, perhaps in tissue culture, of the impact of Wolbachia on virus evolution.
Despite these complications, initial trials with transinfected mosquitoes are encouraging. Following cage experiments with Ae. aegypti and wAlbB (Xi et al., 2005) , experiments with wMel and caged Ae. aegypti in semi-field conditions have shown rapid establishment of infection in the insect population and inhibition of DENV replication . Release experiments into the Australian environment have achieved spread of wMel into two natural Ae. aegypti populations within months of release of infected adult mosquitoes (Hoffmann et al., 2011) , with no detectable adverse effects on the environment and human health. Indeed, new field trials are set to begin in Australia (http:// www.eliminatedengue.com/progress).
Wolbachia offers a unique opportunity to potentially understand and control arbovirus transmission. Indeed, more recent studies have indicated the use of Wolbachia to control Plasmodium infections, opening the field further (Bian et al., 2013a) . For virologists, investigating and potentially manipulating the mechanisms underlying the inhibition of virus transmission by Wolbachia will remain an interesting and challenging task.
